Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  SkyePharma PLC    SKP   GB00B3BFNB64

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
08/24/2015 08/25/2015 08/26/2015 08/27/2015 08/28/2015 Date
257.75(c) 267.25(c) 291.5(c) 310(c) 325.25(c) Last
93 088 135 583 3 268 646 607 894 169 935 Volume
+0.88% +3.69% +9.07% +6.35% +4.92% Change
More quotes
Financials ( GBP)
Sales 2015 89,4 M
EBIT 2015 22,3 M
Net income 2015 16,9 M
Finance 2015 7,24 M
Yield 2015 -
Sales 2016 105 M
EBIT 2016 26,1 M
Net income 2016 20,7 M
Finance 2016 11,1 M
Yield 2016 -
PER 2015 24,09
PER 2016 15,49
EV / Sales 2015 3,73x
EV / Sales 2016 3,15x
Capitalization 341 M
More Financials
Company
SkyePharma Plc is a UK based pharmaceutical company.It engages in the research and development, licensing, manufacturing, marketing and distribution of prescription pharmaceutical products.The company approves products in the areas of oral, inhalation and topical delivery.SkyePharma was founded by... 
Sector
Pharmaceuticals
Calendar
03/17Earnings Release
More about the company
Surperformance© ratings of SkyePharma PLC
Trading Rating : Investor Rating :
More Ratings
Latest news on SKYEPHARMA PLC
08/26 SKYEPHARMA : 2015 Interim Results
08/26 SKYEPHARMA : 2015 Interim Results
08/26 SKYEPHARMA : IN THE KNOW: FinnCap Calls Skyepharma Growth Stock, Initiates With ..
08/26 SKYEPHARMA : Confident For 2015 As It Swings To First Half Profit
08/10 SKYEPHARMA : Notice of Interim Results
06/26 SKYEPHARMA : Interim Results Pre-close Trading Update
06/25 SKYEPHARMA : Says On Track For 2015 On Good Flutiform Performance
05/13 BARCLAYS : supports Skyepharma with a GBP25 million credit facility to support o..
More news
Sector news : Pharmaceuticals - NEC
05:03a Largest Dutch pension fund exits Mylan over death penalty concerns
03:35a ASTRAZENECA : to present further research into long-term prevention of cardiovas..
08/28 PERRIGO : BRIEF: Mylan shareholders approve Perrigo takeover bid
More sector news : Pharmaceuticals - NEC


Comments 
Advertisement
Chart SKYEPHARMA PLC
Duration : Period :
SkyePharma PLC Technical Analysis Chart | SKP | GB00B3BFNB64 | 4-Traders
Full-screen chart
Technical analysis trends SKYEPHARMA PLC
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions